RUKOBIA

This brand name is authorized in Austria, Estonia, Spain, Finland, France, Croatia, Ireland, Italy, Lithuania, Poland, Romania, United States

Active ingredients

The drug RUKOBIA contains one active pharmaceutical ingredient (API):

1 Fostemsavir UNII 2X513P36U0 - FOSTEMSAVIR TROMETHAMINE

Fostemsavir is an HIV-1 antiretroviral agent. It used in combination with other antiretroviral(s) for the treatment of human immunodeficiency virus type 1 (HIV-1) infection, Read about Fostemsavir

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
RUKOBIA Extended-release tablet	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J05AX29		J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AX Other antivirals
Discover more medicines within J05AX29

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1840452
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 1201518001
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 036262
Country: FR	Base de données publique des médicaments	Identifier(s): 69610664
Country: IT	Agenzia del Farmaco	Identifier(s): 049362015, 049362027
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1091816
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100443935
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W68505001, W68505002
Country: US	FDA, National Drug Code	Identifier(s): 49702-250